NCT02389309 2026-03-09Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Active not recruiting14 enrolled